ImmunoCellular Therapeutics, Ltd. (IMUC)
USD 0.17
(0.06%)
USD 0.17
(0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.42 Million | -2.62 Million | -2.3 Million | -1.23 Million | -16.67 Million | -19.86 Million |
| Net Income | -1.61 Million | -2.64 Million | -2.67 Million | -1.45 Million | -14.31 Million | -22.08 Million |
| Depreciation & Amortization | - | - | - | - | 47.76 Thousand | 75.11 Thousand |
| Deferred income taxes | - | - | - | - | 2.35 Million | - |
| Stock-based compensation | - | - | - | - | 492.18 Thousand | 1.22 Million |
| Change in working capital | 492.78 Thousand | 379.06 Thousand | 332.76 Thousand | 137.12 Thousand | 1.58 Million | 2.91 Million |
| Other non-cash items | -302.03 Thousand | -355.48 Thousand | 40.02 Thousand | 78.84 Thousand | -6.83 Million | -2 Million |
| Investing Cash Flow | - | - | - | - | 1326.00 | -4015.00 |
| Investments in PPE | 4.00 | - | - | - | - | -4015.00 |
| Acquisitions | - | - | - | - | 1326.00 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.08 Million | 1.75 Million | 3.52 Million | 1.5 Million | 11.86 Million | 8.7 Million |
| Debt repayment | -1.08 Million | -1.75 Million | -2.5 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.5 Million | 11.86 Million | 7.03 Million |
| Other Financing Activities | - | - | 1.02 Million | 2000.00 | - | 1.66 Million |
| Accounts receivables | - | - | - | - | -1.56 Million | 788.67 Thousand |
| Accounts payables | - | - | - | - | 490.95 Thousand | 125.36 Thousand |
| Inventory | - | - | - | - | 146.43 Thousand | -221.54 Thousand |
| Other working capital | 492.78 Thousand | 379.06 Thousand | 332.76 Thousand | 137.12 Thousand | 2.51 Million | 2.22 Million |
| Cash at beginning of period | 613.24 Thousand | 1.48 Million | 262.97 Thousand | 6.62 Million | 11.43 Million | 22.6 Million |
| Cash at end of period | 278.26 Thousand | 613.24 Thousand | 1.48 Million | 262.97 Thousand | 6.62 Million | 11.43 Million |
| Capital Expenditure | 4.00 | - | - | - | - | -4015.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -334.98 Thousand | -873.32 Thousand | 1.22 Million | -6.36 Million | -4.8 Million | -11.16 Million |
| Free Cash Flow | -1.42 Million | -2.62 Million | -2.3 Million | -1.23 Million | -16.67 Million | -19.86 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.61 Million | - | - | - | -2.64 Million | -464.52 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 492.78 Thousand | - | - | - | 379.06 Thousand | 93.24 Thousand |
| Other non-cash items | -302.03 Thousand | - | - | - | -355.48 Thousand | -316.65 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.08 Million | - | - | - | 1.75 Million | 750 Thousand |
| Debt repayment | -1.08 Million | - | - | - | -1.75 Million | -750 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 492.78 Thousand | - | - | - | 379.06 Thousand | 93.24 Thousand |
| Cash at beginning of period | 613.24 Thousand | - | - | - | 1.48 Million | 551.17 Thousand |
| Cash at end of period | 278.26 Thousand | - | - | - | 613.24 Thousand | 613.24 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -334.98 Thousand | - | - | - | -873.32 Thousand | 62.06 Thousand |
| Free Cash Flow | -1.42 Million | - | - | - | -2.62 Million | -687.93 Thousand |
PSHG
HEAL
WFHG
GSL-PB
ALMDP
BALD-B